Skip to content

apotheek de plaats: what changed

BE 0447.808.616NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€127,107
2024 · -€93,975+€221,082
Equity
€214,239
2024 · €213,133+€1,107
Cash
€22,757
2024 · €5,810+€16,947
Balance sheet total
€1.1m
2024 · €981,123+€149,186

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€124,237

    up €124,237 (+25.2%), from €493,368 to €617,606

    of which Other amounts receivable: +€125,407

  • Tangible fixed assets +€17,430

    up €17,430 (+9.1%), from €191,956 to €209,386

    of which Other tangible fixed assets: +€13,450

  • Cash +€16,947

    up €16,947 (+292%), from €5,810 to €22,757

    mainly Other debts (+€146,414) and Net result for the year (+€127,107)

  • Stocks and contracts -€12,102

    down €12,102 (-6.3%), from €191,082 to €178,980

Equity and liabilities
  • Other debts +€146,414

    up €146,414 (+47.3%), from €309,480 to €455,894

  • Trade debts +€37,563

    up €37,563 (+68.3%), from €54,985 to €92,548

  • Debts after one year -€36,491

    down €36,491 (-10.5%), from €346,447 to €309,956

Income statement
  • Gross operating margin -€25,079

    down €25,079 (-9.1%), from €276,436 to €251,356

  • Staff costs +€5,548

    up €5,548 (+4.9%), from €114,355 to €119,904

  • Financial charges +€5,435

    up €5,435 (+35.1%), from €15,503 to €20,937

  • Other operating charges -€3,819

    down €3,819 (-60.2%), from €6,342 to €2,523

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result.

Result 2024 -€93,975
Gross operating margin -€25,079
Staff costs -€5,548
Depreciation -€376
Other operating charges +€3,819
Other operating items +€251,420
Financial income +€2,281
Financial charges -€5,435
Result 2025 €127,107
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€205,016
Investment -€25,737
Financing -€162,332
Cash 2024 €5,810
Net result for the year +€127,107
Depreciation +€4,707
Stocks and contracts +€12,102
Receivables within one year -€124,237
Deferred charges and accrued income +€926
Trade debts +€37,563
Tax, wage and social debts +€516
Other debts +€146,414
Accrued charges and deferred income -€82
Investment in fixed assets (net) -€25,737
Debts after one year -€36,491
Current portion of long-term debt +€159
Contributions, distributions and other -€126,000
Cash 2025 €22,757
brings cash intakes cash out
Every line side by side 51 lines
Line Code 2024 2025 Change %
Total assets 20/58 €981,123 €1,130,310 +€149,186 +15.2%
Fixed assets 21/28 €281,956 €302,986 +€21,030 +7.5%
Tangible fixed assets 22/27 €191,956 €209,386 +€17,430 +9.1%
Land and buildings 22 €179,965 €179,965 = 0.0%
Plant, machinery and equipment 23 €3,723 €5,135 +€1,412 +37.9%
Furniture and vehicles 24 €8,268 €10,836 +€2,568 +31.1%
Other tangible fixed assets 26 - €13,450 +€13,450
Financial fixed assets 28 €90,000 €93,600 +€3,600 +4.0%
Current assets 29/58 €699,167 €827,324 +€128,156 +18.3%
Stocks and contracts in progress 3 €191,082 €178,980 -€12,102 -6.3%
Stocks 30/36 €191,082 €178,980 -€12,102 -6.3%
Amounts receivable within one year 40/41 €493,368 €617,606 +€124,237 +25.2%
Trade receivables 40 €94,427 €93,258 -€1,170 -1.2%
Other amounts receivable 41 €398,941 €524,348 +€125,407 +31.4%
Cash at bank and in hand 54/58 €5,810 €22,757 +€16,947 +292%
Deferred charges and accrued income 490/1 €8,907 €7,981 -€926 -10.4%
Total equity and liabilities 10/49 €981,123 €1,130,310 +€149,186 +15.2%
Equity 10/15 €213,133 €214,239 +€1,107 +0.5%
Contributions 10/11 €37,200 €37,200 = 0.0%
Reserves 13 €175,933 €177,039 +€1,107 +0.6%
Tax-exempt reserves 132 €12,156 €12,156 = 0.0%
Distributable reserves 133 €163,776 €164,883 +€1,107 +0.7%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €767,991 €916,070 +€148,079 +19.3%
Amounts payable after more than one year 17 €346,447 €309,956 -€36,491 -10.5%
Financial debts 170/4 €346,447 €309,956 -€36,491 -10.5%
Amounts payable within one year 42/48 €420,082 €604,734 +€184,652 +44.0%
Current portion of amounts payable after more than one year 42 €39,366 €39,525 +€159 +0.4%
Financial debts 43 €0 - =
Credit institutions 430/8 €0 - =
Trade debts 44 €54,985 €92,548 +€37,563 +68.3%
Suppliers 440/4 €54,985 €92,548 +€37,563 +68.3%
Taxes, remuneration and social security 45 €16,251 €16,767 +€516 +3.2%
Taxes 450/3 - €15 +€15
Remuneration and social security 454/9 €16,251 €16,751 +€501 +3.1%
Other amounts payable 47/48 €309,480 €455,894 +€146,414 +47.3%
Accrued charges and deferred income 492/3 €1,462 €1,380 -€82 -5.6%
Remuneration, social security and pensions 62 €114,355 €119,904 +€5,548 +4.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €4,331 €4,707 +€376 +8.7%
Other operating charges 640/8 €6,342 €2,523 -€3,819 -60.2%
Non-recurring operating charges 66A €251,420 €0 -€251,420 -100%
Gross operating margin 9900 €276,436 €251,356 -€25,079 -9.1%
Operating profit (loss) 9901 -€100,013 €124,223 +€224,235
Financial income 75/76B €21,541 €23,821 +€2,281 +10.6%
Recurring financial income 75 €21,541 €23,821 +€2,281 +10.6%
Financial charges 65/66B €15,503 €20,937 +€5,435 +35.1%
Recurring financial charges 65 €15,503 €20,937 +€5,435 +35.1%
Profit (loss) for the period before taxes 9903 -€93,975 €127,107 +€221,082
Income taxes 67/77 €0 - =
Profit (loss) for the period 9904 -€93,975 €127,107 +€221,082
Profit (loss) for the period to be appropriated 9905 -€93,975 €127,107 +€221,082

Value

latest balance sheet 30-09-2025 · indication, not a valuation or advice

Value of the equity

Indication, not a valuation or advice
€580,941 to €770,470

Midpoint €659,911 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate. Change the assumptions and the value follows.

Adjusted equity €214,239
Capitalised earnings €947,643 to €1.3m
Indication €580,941 to €770,470

Adjusted equity

balance sheet 30-09-2025
Equity (10/15)
€214,239
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€214,239

Capitalised earnings

net result for the year (9904)
2025
€127,107
2024
-€93,975
excluding non-recurring income and charges
€157,445
2023
€113,457
2022
€124,310
2021
€117,574
Average result, excluding non-recurring income and charges
€132,670
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€947,643 / €1.1m / €1.3m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 30 September 2024 and 30 September 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 21 November 2026 via checked.be.